DrugDomain logoDrugDomain

Attributes

UniProt ID
Protein Name
Transcription termination factor Rho
Ligand Name
ADENOSINE-5'-DIPHOSPHATE
DrugBank ID
PDB Ligand Accession
ChEMBL ID
n/a
PubChem ID
n/a
InChIKey
XTWYTFMLZFPYCI-KQYNXXCUSA-N
SMILES
c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N
Drug Action
No data available
Affinity Metrics
No affinity data available

3D Structure

Interactive Mol* view for the current protein-molecule pair.

Structure: 3ICE
Hover over the Mol* viewer to rotate or zoom with the mouse. Move the cursor out of the viewer to go back to normal page scrolling and one-click navigation.
Hover inside the viewer to rotate or zoom. Move out to scroll the page or click links normally.
Color Legend
Unassigned regionsLigand / hetero atomse3iceA2e3iceA4e3iceA5e3iceB2e3iceB4e3iceB5e3iceC2e3iceC4e3iceC5e3iceD2e3iceD4e3iceD5e3iceE10e3iceE11e3iceE12e3iceF1e3iceF2e3iceF3
ECOD domains from experimental PDB structures interacting with ligand DB16833
UniProtDrugBankPDB LigandPDB IDECOD DomainRange Definition
P0AG30DB16833ADP3icee3iceA4A:128-415
P0AG30DB16833ADP3icee3iceB4B:128-415
P0AG30DB16833ADP3icee3iceC4C:128-415
P0AG30DB16833ADP3icee3iceD4D:128-415
P0AG30DB16833ADP3icee3iceE10E:128-415
P0AG30DB16833ADP3icee3iceF3F:128-415
P0AG30DB16833ADP6z9te6z9ta1a:129-417
P0AG30DB16833ADP6z9te6z9tb3b:129-417
P0AG30DB16833ADP6z9te6z9tc1c:129-417
P0AG30DB16833ADP6z9te6z9td3d:129-417
P0AG30DB16833ADP6z9te6z9te3e:129-417
P0AG30DB16833ADP6z9te6z9tf1f:129-417
P0AG30DB16833ADP8q3pe8q3pa1a:129-419
P0AG30DB16833ADP8q3pe8q3pb1b:129-419
P0AG30DB16833ADP8q3pe8q3pc3c:129-419
P0AG30DB16833ADP8q3pe8q3pd3d:129-419
P0AG30DB16833ADP8q3pe8q3pe1e:129-419
P0AG30DB16833ADP8q3pe8q3pf3f:129-419
P0AG30DB16833ADP8q3pe8q3pg2g:129-419
P0AG30DB16833ADP8q3pe8q3ph2h:129-419
P0AG30DB16833ADP8q3pe8q3pi2i:129-419
P0AG30DB16833ADP8q3pe8q3pj3j:129-419
P0AG30DB16833ADP8q3pe8q3pk2k:129-419
P0AG30DB16833ADP8q3pe8q3pl3l:129-419
P0AG30DB16833ADP8q3pe8q3pm1m:129-419
P0AG30DB16833ADP8q3pe8q3pn3n:129-419
P0AG30DB16833ADP8q3pe8q3po1o:129-419
P0AG30DB16833ADP8q3pe8q3pp3p:129-419
P0AG30DB16833ADP8q3pe8q3pq2q:129-419
P0AG30DB16833ADP8q3pe8q3pr3r:129-419
P0AG30DB16833ADP8q3qe8q3qa2a:129-419
P0AG30DB16833ADP8q3qe8q3qb3b:129-419
P0AG30DB16833ADP8q3qe8q3qc2c:129-419
P0AG30DB16833ADP8q3qe8q3qd2d:129-419
P0AG30DB16833ADP8q3qe8q3qe3e:129-419
P0AG30DB16833ADP8q3qe8q3qf1f:129-419
P0AG30DB16833ADP8q3qe8q3qg3g:129-419
P0AG30DB16833ADP8q3qe8q3qh2h:129-419
P0AG30DB16833ADP8q3qe8q3qi2i:129-419
P0AG30DB16833ADP8q3qe8q3qj3j:129-419
P0AG30DB16833ADP8q3qe8q3qk3k:129-419
P0AG30DB16833ADP8q3qe8q3ql3l:129-419
P0AG30DB16833ADP8q3qe8q3qm2m:129-419
P0AG30DB16833ADP8q3qe8q3qn3n:129-419
P0AG30DB16833ADP8q3qe8q3qo1o:129-419
P0AG30DB16833ADP8q3qe8q3qp3p:129-419
P0AG30DB16833ADP8q3qe8q3qq3q:129-419
P0AG30DB16833ADP8q3qe8q3qr2r:129-419